Pharmaceutical Pricing Policies in a Global Market (Turkish version)
Author : OECD
Publisher : OECD Publishing
Page : 242 pages
File Size : 33,3 MB
Release : 2011-12-20
Category :
ISBN : 9758037315
Author : OECD
Publisher : OECD Publishing
Page : 242 pages
File Size : 33,3 MB
Release : 2011-12-20
Category :
ISBN : 9758037315
Author : OECD
Publisher : OECD Publishing
Page : 219 pages
File Size : 27,58 MB
Release : 2008-09-24
Category :
ISBN : 9264044159
This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.
Author : OECD
Publisher : OECD Publishing
Page : 216 pages
File Size : 41,72 MB
Release : 2008-09-29
Category :
ISBN : 9789264044142
This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.
Author : Ed Schoonveld
Publisher : Routledge
Page : 464 pages
File Size : 42,22 MB
Release : 2016-02-24
Category : Business & Economics
ISBN : 1317019296
Public debate on the rising cost of new biotechnology drug treatments has intensified over the last few years as healthcare budget pressures have mounted under a strained economy. Meanwhile, the demand for new, effective medical and drug treatments continues to rise as unhealthy lifestyles cause further increases in diabetes and cardiovascular disease. Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death? Ed Schoonveld explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. His insights will help a wide range of audiences, from healthcare industry professionals to policy makers and the broader public, to gain a better understanding of this highly complex and emotionally charged field. The Price of Global Health is recognized as a valued and unique reference book that covers a complete array of topics related to global pharmaceutical pricing. It contains an in-depth but straightforward exploration of the pharmaceutical pricing strategy process, its underlying market access, general business and ethical considerations, and its implications for payers, physicians and patients. It is a much-needed and invaluable resource for anybody interested or involved in, or affected by, the development, funding and use of prescription drugs. In particular, it is of critical importance to pharmaceutical company executives and other leaders and professionals in commercialization and drug development, including marketing, business development, market access and pricing, clinical development, drug discovery, regulatory affairs, health outcomes, market research and public affairs. The second edition includes new chapters on payer value story development, oncology, orphan drugs and payer negotiations. Furthermore, many country chapters have been substantially updated to reflect changes in the healthcare systems, including the Affordable Care Act in the US, AMNOG in Germany, medico-economic requirements in France and many other country-specific changes. Lastly, almost every chapter has been updated with new examples and illustrations.
Author : world health organization
Publisher :
Page : 0 pages
File Size : 15,70 MB
Release : 2022
Category :
ISBN :
Author : Zaheer-Ud-Din Babar
Publisher : Springer
Page : 410 pages
File Size : 18,60 MB
Release : 2014-12-05
Category : Business & Economics
ISBN : 3319121693
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Author :
Publisher : World Health Organization
Page : 70 pages
File Size : 25,37 MB
Release : 2020-09-29
Category : Business & Economics
ISBN : 9240011870
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author :
Publisher : World Health Organization
Page : 2 pages
File Size : 30,23 MB
Release : 2021-06-21
Category : Business & Economics
ISBN : 9240024638
Author :
Publisher : World Health Organization
Page : 2 pages
File Size : 26,63 MB
Release : 2021-06-21
Category : Business & Economics
ISBN : 9240024573
Author :
Publisher : World Health Organization
Page : 2 pages
File Size : 18,65 MB
Release : 2021-06-21
Category : Business & Economics
ISBN : 9240024085